@drewmoghanaki
MD, MPH - Lung Cancer Specialist and Professor, David Geffen School of Medicine at UCLA | Co-Director, Lung Precision Oncology Program, VA Greater Los Angeles https://www.uclahealth.org/radonc/drew-moghanaki
Is there a prize for finding toxicity? Is that the ultimate goal? It sure seems to be that way for many academic clinicians in this specialty.
I believe our patients want us to have a different objective other than hunting for harms.
Why do #radonc articles start with the T word? Who started this self-defeatist approach and why isn’t anyone talking about how this makes the R word even scarier?
Do something.